I know it’s a long way down the track but I always invest with...

I know it’s a long way down the track but I always invest with optionality as a key component. I ask: What am I paying for today and what I am paying for or not really paying for that may eventuate in the future?

As stand alone technologies Fatty Liver Disease Detection and an alternative to blood tests are potentially very large markets. This is why investing in platform technologies with future optionality can be lucrative. You pay for the immediate opportunity (Stroke) and often get the other longer shots or less developed opportunities thrown in (even TBI is one of these now).

EMV has the management, technology and brain power (pardon the pun) to potentially bring these technologies to market into the future. Of course only after we deal with Stroke and TBI etc. Although Professor Crozier stated he would be happy to pursue opportunities concurrently as long as they received dedicated grants for that opportunity and it did not disturb the main priorities in any way.

Thanks for sharing Vintage, you are genuine resource on this forum and always appreciated.